NCT02246842View on ClinicalTrials.gov

A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2004

Conditions
Healthy
Interventions
BIOLOGICAL

D-Gam® (human anti-D immunoglobulin)

BIOLOGICAL

Rhophylac® (human anti-D immunoglobulin)

Trial Locations (1)

GU2 7YG

Guildford Clinical Pharmacology Unit, Unit 34, Surrey Technology Centre, Surrey Research Park

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER